These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9820876)

  • 1. Characterization of guanoxabenz reducing activity in rat brain.
    Dambrova M; Uhlén S; Wikberg JE
    Pharmacol Toxicol; 1998 Oct; 83(4):158-63. PubMed ID: 9820876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. II. Description of a xanthine-dependent enzymatic activity in spleen cytosol.
    Dambrova M; Uhlén S; Welch CJ; Prusis P; Wikberg JE
    Biochem Pharmacol; 1998 Nov; 56(9):1121-8. PubMed ID: 9802321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. I. Description of an enzymatic activity in spleen membranes.
    Uhlén S; Dambrova M; Tiger G; Oliver DW; Wikberg JE
    Biochem Pharmacol; 1998 Nov; 56(9):1111-9. PubMed ID: 9802320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an N-hydroxyguanidine reducing activity of xanthine oxidase.
    Dambrova M; Uhlén S; Welch CJ; Wikberg JE
    Eur J Biochem; 1998 Oct; 257(1):178-84. PubMed ID: 9799117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz.
    Clement B; Demesmaeker M; Linne S
    Chem Res Toxicol; 1996 Jun; 9(4):682-8. PubMed ID: 8831810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2.
    Clement B; Demesmaeker M
    Drug Metab Dispos; 1997 Nov; 25(11):1266-71. PubMed ID: 9351903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.
    Uhlén S; Wikberg JE
    Br J Pharmacol; 1991 Nov; 104(3):657-64. PubMed ID: 1665747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system.
    Berridge TL; Gadie B; Roach AG; Tulloch IF
    Br J Pharmacol; 1983 Mar; 78(3):507-15. PubMed ID: 6132641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evidence for two alpha 2B-adrenoreceptor isoforms in the renal cortex of salt-sensitive and salt resistant Sabra rats. Effect of salt loading].
    Le Jossec M; Cloix JF; Dausse JP
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1229-32. PubMed ID: 8572879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype.
    Sastre M; García-Sevilla JA
    J Neurochem; 1994 Sep; 63(3):1077-85. PubMed ID: 7914222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for the existence of two forms of alpha 2B-adrenoceptors in rat.
    Xia Y; Uhlén S; Chhajlani V; Lien EJ; Wikberg JE
    Pharmacol Toxicol; 1993 Jan; 72(1):40-9. PubMed ID: 8095097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacological studies in rodents on the action of RX 781094, a new selective alpha 2-adrenoceptor antagonist.
    Dettmar PW; Lynn AG; Tulloch IF
    Neuropharmacology; 1983 Jun; 22(6):729-37. PubMed ID: 6136932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interaction of guanabenz with receptor binding sites in rat brain and kidney.
    Gould RJ; Murphy KM; Snyder SH; Strandhoy JW; Dunlap CE
    Res Commun Chem Pathol Pharmacol; 1989 Oct; 66(1):3-19. PubMed ID: 2559439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
    Wallace DR; Muskardin DT; Zahniser NR
    Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.
    Dambrova M; Baumane L; Kiuru A; Kalvinsh I; Wikberg JE
    Arch Biochem Biophys; 2000 May; 377(1):101-8. PubMed ID: 10775447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of alpha-adrenoceptors in the nucleus reticularis gigantocellularis involved in the cardiovascular depressant effects of guanabenz in the rat.
    Lim HC; Chong OK; Chan SH
    Neuropharmacology; 1988 Mar; 27(3):243-9. PubMed ID: 2897642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.
    Roach AG; Doxey JC; Strachan DA; Cavero I
    J Pharmacol Exp Ther; 1983 Nov; 227(2):421-8. PubMed ID: 6138427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanabenz, guanochlor, guanoxan and idazoxan bind with high affinity to non-adrenergic sites in pig kidney membranes.
    Vigne P; Lazdunski M; Frelin C
    Eur J Pharmacol; 1989 Jan; 160(2):295-8. PubMed ID: 2527160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.